CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed
Clinical trial NCT05162976 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05162976
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-03
- Primary completion
- 2027-04-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.